Subscription Center
Nov 7, 2008 02:25 PM | 2
Federal drug regulators have seized batches of the tainted blood thinner heparin from a Cincinnati manufacturer that used a Chinese-made ingredient linked to 81 U.S. deaths earlier this year.
The Food and Drug Administration (FDA) said yesterday that it took 11 lots of heparin from Celsus Laboratories that was contaminated with over-sulfated chondroitin sulfate (OSCS), a chemical used only to make fake blood thinner. The ingredient mimics heparin's anti-clotting properties but can cause severe allergic reactions and dangerously low blood pressure, according to reports the agency received beginning in January.
No patients were harmed by the tainted Celsus products, which were to be used in medical devices, not as injections, FDA spokeswoman Karen Riley said today.
Celsus informed its customers that the products were contaminated after they were shipped between January and April, but didn’t tell buyers to destroy or recall them if they'd already been embedded in the companies' devices, Riley said. The tainted heparin was sold to universities, research, chemical and research-supply facilities in the U.S, Japan, Canada, Australia and Europe. "This was a contaminated product, and we don’t think that [Celsus] did enough," Riley said. "We decided to seize the remainder and destroy it."
Facilities that may have bought heparin from Celsus should contact the company to make sure they're not using products from the seized lots, the FDA says. A receptionist who answered the phone at Celsus this morning said the company had no comment.
The FDA has issued 13 recalls of tainted heparin products so far this year. Scientists are racing to develop safer, synthetic versions of the anticoagulant to reduce American dependence on China for the drug, which is traditionally made from a complex carbohydrate derived from pigs’ intestines.
Riley declined to give a number for consumers or businesses to call about the heparin seizure, saying Celsus had notified its customers about the tainted product.
Image by iStockphoto/Bogdan Pop
Tags:
FDA,
blood,
anticoagulant,
heparin
More News Blog:
Next: Obama considers candidates for first chief tech officer
Previous: Brain, spinal cord injuries could be helped by nerve regrowth technique
See what we're tweeting about
Dhunterauthor Nuevo Verdad: Geotrippin’ Parte the – Oh, Crap, I Forgot Cape Blanco!: Going through photos for the next insta... http://t.co/Sj3ldKqzuD
DNLee5 “@MonasLists: too tired to be awake, too awake to be asleep” // This, me, every morning #thestruggle DNLee5 Getting into the spirit, Happy Africa Day, Uhuru & Pamoja! #DispatchesDNLee
Deadline: Jul 30 2013
Reward: $100,000 USD
The Seeker desires a method for producing pseudoephedrine products in such a way that it will be extremely difficult for clandestine che
Deadline: Jul 25 2013
Reward: Varies
This challenge provides an opportunity for Solvers to build a web-based or mobile “app” to explore data relationships in scholarly conte
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
2 Comments
Add CommentTime to cut trade with China huh?
Reply | Report Abuse | Link to thisHi guys, intervention is a best way to overcome the drug addiction. So, please encourage your family members or friends to go on with intervention if they drug addicted.
Reply | Report Abuse | Link to this_______________________________________________________________
Mark Fletcher
<a href="http://www.addictionlink.org/drug-rehab-center/ohio">ohio drug rehab</a>